Scientists have taken a major step toward protecting the very cells that make sharp, colorful vision possible. By testing ...

Please provide your email address to receive an email when new articles are posted on . Price said pharmaceuticals are under study for neurotrophic keratitis, nonhealing epithelial defects and limbal ...

Maria Grant, M.D., FARVO, professor and Eivor and Alston Callahan, M.D., Endowed Chair in Ophthalmology, continues to shape the future of retinal disease research through her pioneering contributions ...

ZUG, Switzerland, 16 March, 2026 -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (Oculis), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical ...